Americas (WHO region) vs Kyrgyzstan: Confirmed cases of MDR-TB
Americas (WHO region)
2,967
in 2012
Kyrgyzstan
958
in 2012
Americas (WHO region) rank
10th
Kyrgyzstan rank
10th
Confirmed cases of MDR-TB over time
- Americas (WHO region)
- Kyrgyzstan
How they compare
Americas (WHO region) currently reports 2,967 against 958 in Kyrgyzstan, a difference of 2,009.
That makes Americas (WHO region)'s figure about 3.1 times Kyrgyzstan's.
Across all 8 years both countries report, Americas (WHO region) has been ahead every year.
Americas (WHO region) ranks 10th and Kyrgyzstan ranks 10th of 11 groups.
Americas (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2,872 | 540.2 | 2,331 | Americas (WHO region) |
| 2010s | 3,034 | 776.67 | 2,257 | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb, Americas (WHO region) or Kyrgyzstan?
- Americas (WHO region), at 2,967 against 958 in Kyrgyzstan as of 2012.
- What is the difference in confirmed cases of mdr-tb between Americas (WHO region) and Kyrgyzstan?
- 2,009, with Americas (WHO region) ahead.
- How many years of comparable data are there for Americas (WHO region) and Kyrgyzstan?
- 8 years are reported by both, from 2005 to 2012.
- How do Americas (WHO region) and Kyrgyzstan rank globally for confirmed cases of mdr-tb?
- Americas (WHO region) ranks 10th and Kyrgyzstan ranks 10th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.